Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Board Change

22 Oct 2021 07:00

RNS Number : 8818P
Microsaic Systems plc
22 October 2021
 

22 October 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board Change

 

Microsaic (AIM: MSYS), announces that, after 6 years of service, Bevan Metcalf, will be retiring as Finance Director on 17 December 2021. To ensure a smooth transition, the Company has appointed an Interim Head of Finance (non-board level), until a permanent successor is appointed.

 

Gerry Brandon, Chairman commented:

"Bevan has been a valued colleague since 2015. He has played a valuable role in supporting the management team through his vast knowledge and experience working within industry and more recently in the development and recent turnaround of the Company. I would like to thank him for the tremendous contribution that he has made to Microsaic since his appointment as Finance Director more than 6 years ago. On behalf of our shareholders, advisors and everyone at Microsaic I would like to wish him a happy and healthy retirement."

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO - Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

About Microsaic

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANEFALDFFFA
Date   Source Headline
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20212:13 pmRNSHolding(s) in Company
16th Feb 20219:00 amRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSFramework Services Agreement
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20215:59 pmRNSHolding(s) in Company
8th Feb 20215:58 pmRNSHolding(s) in Company
8th Feb 202111:08 amRNSHolding(s) in Company
8th Feb 202111:06 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 20215:02 pmRNSHolding(s) in Company
5th Feb 20213:22 pmRNSHolding(s) in Company
5th Feb 20218:05 amRNSDirector/PDMR Shareholding
5th Feb 20218:01 amRNSBoard Changes
4th Feb 202110:22 amRNSResult of General Meeting
29th Jan 20212:05 pmRNSSecond Price Monitoring Extn
29th Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 20215:26 pmRNSFull Exercise of Broker Option
19th Jan 20212:06 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 202111:05 amRNSSecond Price Monitoring Extn
19th Jan 202111:00 amRNSPrice Monitoring Extension
19th Jan 20219:05 amRNSSecond Price Monitoring Extn
19th Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSFundraising, Board Changes and Notice of GM
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSStatement re. share price movement
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.